Approved Treatment Hubs
These treatment hubs are built for US approved-treatment decision flows. Each hub covers the official product landscape, cost friction, provider routing, and tracker next steps in one structured, source-backed page.
Semaglutide Treatment Guide: Wegovy, Ozempic, Cost and Provider Paths
In the United States, semaglutide is not one generic treatment path. It is a family of branded, indication-specific prescription pathways that can differ materially on goal, dose form, coverage, and follow-up workflow.
Tirzepatide Treatment Guide: Zepbound, Mounjaro, Cost and Provider Paths
In the United States, tirzepatide decisions usually split between weight-management and diabetes-oriented branded workflows. That makes provider fit, cost structure, and treatment continuity more important than generic brand awareness.
This content is for informational purposes only and does not constitute medical advice.